Risk Factors for Recurrence of Stone Formation in Patients with Nephrolithiasis and Post-COVID Syndrome Undergoing Metaphylactic Treatment
Article Sidebar
Main Article Content
Abstract
Today, the problem of urolithiasis (UL) as a metabolic disorder characterized by the formation of stones in the kidneys, remains extremely relevant due to its prevalence in urological practice (ranking second only to urinary tract infections), its tendency toward frequent recurrence (30–80%), and serious complications, especially among individuals of working age, remains extremely relevant. UL can lead to renal failure, disability, and mortality among patients.
Downloads
Article Details
Issue
Section
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
How to Cite
References
Samchuk, P. O., Krasyuk, O. Y., Iskenderov, R. K., et al. (2023). Urolithiasis: Current Approaches to Classification, Diagnosis, and Treatment. Men’s Health, (2), 60–67.
Wagner C. A (2021). Etiopathogenic factors of urolithiasis. Arch. Esp. Urol., 74, (1), 16-23.
Nitkin, D. M., & Gapenko, A. D. (2021). Current aspects of the prevention of calcium urolithiasis: practical recommendations. Health of Man, (2), 14–20.
Socarrás M. E. R., Esperto, F., Bapstistussi, M. D. et al. (2020). Endourology (Lithiasis). Management, surgical considerations and follow-up of patients in the COVID-19 era. International braz. j. urol., 46, 39-49.
Kasiri Hossein et al. (2022). The Increased Risk of Renal Stones in Patients With COVID-19 Infection. Pharmaceutical and Biomedical Research, 8, (4), 333-340.
Vozianov S. O., Chernenko V. V., Nikulina G. G., Mygal L. Ya., et al. (2020). Dynamics of renal parenchyma functional recovery and normalization of key risk factors for calcium oxalate nephrolithiasis in urine against the background of complex metaphylactic therapy. Health of Man, (3), 85–88.